https://es.marketscreener.com/cotizacion/accion/2SEVENTY-BIO-INC-128358117/noticia/Regeneron-Pharmaceuticals-Inc-NasdaqGS-REGN-complet-la-adquisici-n-de-la-cartera-de-I-D-de-2s-46330255/?utm_source=telegram&utm_medium=social&utm_campaign=share